Home > Insider Trading > Filing (0001712467-20-000025)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1537917	Tyme Technologies Inc.	TYME	Pharmaceutical Preparations (2834)	453864597

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1712467	Michael Demurjian	157 Broad Street Suite 304 Red Bank NJ 07701		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2019-12-30	20,000	$1.07	25,990,521	No	4	S	Direct
Common Stock	Disposition	2020-02-03	20,000	$1.37	25,810,521	No	4	S	Direct
Common Stock	Disposition	2020-06-22	20,000	$1.36	25,518,546	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The original Form 4 is being amended by this Form 4 amendment solely to correct an administrative error which misreported the number of shares beneficially owned by the reporting person following the transaction reflects a reduction in the number of shares reported as beneficially owned by the reporting person by 920,000 and when in fact the reduction should be 20,000 shares.
The original Form 4 is being amended by this Form 4 amendment solely to correct an administrative error which misreported the number of shares beneficially owned by the reporting person following the transaction and reflects a correction to the number of shares reported as beneficially owned by the reporting person.